Eli Lilly (LLY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LLY Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Eli Lilly manages its resources, obligations, and shareholder equity.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/LLY/balance-sheets
https://api.csimarket.com/api/v1/companies/LLY/fundamentals
https://api.csimarket.com/api/v1/companies/LLY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent4,885.00
Short-term Investments, Total0.00
Cash & Short-term Investments4,885.00
Accounts receivable22,089.00
Other Receivables, Net, Current3,142.00
Inventories18,194.00
Other current assets0.00
Prepaid Expense, Current AS16,862.00
Total Current Assets65,263.00
Equipment/Property/Plant Net32,188.00
Goodwill net9,874.00
Intangible Assets18,084.00
Long-term investments4,013.00
Other Assets18,650.00
Total Assets148,072.00
Liabilities
Accounts Payable, Current AC5,793.00
Employee-related Liabilities, Current AC2,292.00
Debt, Current LI2,517.00
Other current liabilities36,394.00
Taxes Payable, Current, Total0.00
Total Current Liabilities46,996.00
Long-term debt46,986.00
Total Long-term Debt46,986.00
Combined Long+Short Total Debt (filer-reported)-
Accrued Income Taxes, Noncurrent AC16,070.00
Other longterm liabilities7,749.00
Sales Rebates And Discounts17,547.00
Total Liabilities107,801.00
Stockholders' Equity
Common Stock Shares Held In Employee Trust-3,013.00
Common Stock Value588.00
Additional Paid In Capital Common Stock7,309.00
Retained Earnings / Accumulated Deficit38,016.00
Accumulated Other Comprehensive Income-2,629.00
Other Equity-2,629.00
Common Stockholder's Equity40,271.00
Non-controlling interests & other0.00
Total Stockholder's Equity40,271.00
Liabilities & Stockholder's Equity148,072.00
4 historic quarters locked

Sign in to unlock the full Eli Lilly balance sheet history.

About Eli Lilly and Co Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: October 29, 2026
  • Source: lly-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000059478-26-000108

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI